Lifeboat Foundation

Is working to pioneer the full scope of everything that exists a duty? I have been contemplating aspects of that question for some years now. Here I move in the direction of articulating its nature and making the case by drawing out correlations with life extension and Immanuel Kant’s thoughts in The Metaphysical Elements of Ethics.

“IV. What are the Ends which are also Duties? They are: A. Our own perfection, B. Happiness of others.”

His notion of “categorical imperative” is that of a universally applicable, non-contradictory, absolute necessity which everyone can use pure practical reason to understand without it needing to be experienced or taught to them.

He says that “ethics may also be defined as the system of the ends of the pure practical reason.”

Continue reading “The Nature of Indefinite Life Extension in Context of Immanuel Kant’s Insights on Ethics and Duty” »

Hard as it is to believe, for the first time the life expectancy for Americans (not counting the effect of wars) has https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/”>dropped for two consecutive years. Perhaps less hard to believe is that this is https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/”>not true across economic levels. The richest Americans are gaining in longevity, indeed to unprecedented levels. The poor don’t have it so well, and in the U.S., this includes the shrinking middle class, who are also dying earlier. With the widening income gap, there’s a growing discrepancy between life expectancies for the rich and poor. Depending on geography, those on the lower end of the income bracket spread can expect to live 20 years less than their better-off counterparts, a shocking finding from an http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918”>in-depth study coming out of the University of Washington.

Intervene Immune is a company focused on the age-related decline of the immune system, which is known as immunosenescence. Here, Bobby Brooke, CEO of Intervene Immune, discusses the clinical potential of regenerating the thymus as a means of reversing age-related immune system decline.

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This was a conference designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Continue reading “The Potential of Thymus Regeneration” »

New Aubrey interview.

Today we explore human longevity and life extension efforts focused on adding healthy years to a person’s lifespan, and even reversing the aging process.

Continue reading “Life Extension & Human Longevity with Dr. Aubrey de Grey on MIND & MACHINE” »

Can we delay or even reverse the aging process? The scientists at the Sinclair Lab at Harvard Medical School think so, and you can help them find out!

https://www.lifespan.io/nmn

So far the NAD+ Mouse Project by Dr. David Sinclair and his team at Harvard Medical School has raised over $43,265 for an exciting research project that is targeting the aging process. Help us reach $45,000 so we can expand the project even more.

Sputnik’s interlocutor has a medallion with a phone number and instructions for what to do if he dies. So it’s highly likely that if he dies he will end up where he and Sputnik have come.

Freeze Your Own Grandma

Continue reading “‘Your Blood Will Freeze’: How Foreigners Seek Immortality in Russia” »

Senolytics are the first therapies that directly target the aging process to delay or prevent age-related diseases and are now in human trials. Today we thought it was the ideal time to have a look at how they work and the companies involved.

Senescent cells and aging

Continue reading “The First Therapy that Targets Aging is in Human Trials Now” »

As we get older, more and more of our the cells in our bodies become dysfunctional and enter into a state known as senescence. These senescent cells no longer divide or support the tissues and organs of which they are part; instead, they secrete a range of harmful inflammatory chemical signals, which are known as the senescence-associated secretory phenotype (SASP).

For more aging research news visit: https://www.leafscience.org/

1st conference upcoming in Nov. 2018, in Spain.

Cookies Policy This site uses cookies for you to have the best user experience. If you continue to browse you are giving your consent to the acceptance of the aforementioned cookies and acceptance of our cookies policy, click the link for more information.